Revvity was listed on the New York Stock Exchange, and TD Cowen subsequently restated its buy rating on the company's shares.
2 reports, 2 independent
Updated Aug 4
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Revvity was listed on the New York Stock Exchange, and TD Cowen subsequently restated its buy rating on the company's shares.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- TD Cowen restated a 'buy' rating on Affiliated Managers Group (AMG) on June 6, 2026.
- TD Cowen reaffirmed a buy rating on Alaska Airlines.
- Benchmark and TD Cowen reissued buy ratings on Strive shares on June 30, 2026.
- TD Cowen issued a buy rating and price target for Dexcom on October 9, 2026.
- TD Cowen reiterated a buy rating on MBX Biosciences shares, and Citigroup restated an outperform rating on the company.